SARS, MERS and COVID-19 status in HIV-Positive Patients: A Systematic Review SARS, MERS and COVID-19 in HIV-positive patients
Journal of Cellular & Molecular Anesthesia,
Vol. 6 No. 1 (2021),
17 March 2021
,
Page 75-80
https://doi.org/10.22037/jcma.v6i1.32203
Abstract
Coronavirus can cause lots of viral diseases such as the common cold, Middle East respiratory Syndrome coronavirus (MERS-CoV), Severe acute respiratory syndrome coronavirus (SARS-CoV) and Coronavirus disease 2019 (COVID-19). Coronavirus and Human immunodeficiency virus (HIV) are considered as RNA viruses.The use of antivials in HIV-positive patients chalenges the development and the treatment of the patients with SARA, MERS and COVID-19. We reviewed the relevant studies in this regard to identify SARS, MERS and COVID-19 status in HIV-positive patients.
- SARS
- MERS
- HIV
- AIDS
- COVID-19
How to Cite
References
References
Gralinski LE, Menachery VD. Return of the Coronavirus: 2019- nCoV. Viruses. 2020;12(2).
Zhao S, Musa SS, Lin Q, Ran J, Yang G, Wang W, et al. Estimating the Unreported Number of Novel Coronavirus (2019-nCoV) Cases in China in the First Half of January 2020: A Data-Driven Modelling Analysis of the Early Outbreak. J Clin Med. 2020;9(2):388.
Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269-71.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33.
Tabatabaii SA, Soltani P, Khanbabaee G, Sharma D, Valizadeh R, Farahbakhsh N, et al. SARS Coronavirus 2, Severe Acute Respiratory Syndrome, and Middle East Respiratory Syndrome in Children: A Review on Epidemiology, Clinical Presentation, and Diagnosis. Arch Pediatr Infect Dis. 2020;8(4):e104860.
Altuntas Aydin O, Kumbasar Karaosmanoglu H, Kart Yasar K. HIV/SARS-CoV-2 coinfected patients in Istanbul, Turkey. J Med Virol. 2020;92(11):2288-90.
De Groot AS. How the SARS vaccine effort can learn from HIV-speeding towards the future, learning from the past. Vaccine. 2003;21(27-30):4095-104.
Lotfi B, Farshid S, Dadashzadeh N, Valizadeh R, Rahimi MM. Is Coronavirus Disease 2019 (COVID-19) Associated with Renal Involvement? A Review of Century Infection. Jundishapur J Microbiol. 2020;13(4):e102899.
Edwards M, Linden P, Banerjee A. A case of nephrotic syndrome secondary to HIV immune complex kidney disease. J Nephropathol. 2021;10(1):e09.
Rahimi MM, Jahantabi E, Lotfi B, Forouzesh M, Valizadeh R, Farshid S. Renal and liver injury following the treatment of COVID- 19 by remdesivir. J Nephropathol. 2021;10(2):e10.
Unaids J. Fact sheet—latest global and regional statistics on the status of the AIDS epidemic. Geneva: UNAIDS. 2017.
Ballester-Arnal R, Gil-Llario MD. The Virus that Changed Spain: Impact of COVID-19 on People with HIV. AIDS Behav. 2020;24(8):2253-7.
Chen XP, Li GH, Tang XP, Xiong Y, Chen XJ, Cao Y. Lack of severe acute respiratory syndrome in 19 AIDS patients hospitalized together. J Acquir Immune Defic Syndr. 2003;34(2):242-3.
Blanco JL, Ambrosioni J, Garcia F, Martínez E, Soriano A, Mallolas J, et al. COVID-19 in patients with HIV: clinical case series. Lancet HIV. 2020;7(5):e314-e6.
Algarin AB, Varas-Rodríguez E, Valdivia C, Fennie KP, Larkey L, Hu N, et al. Symptoms, Stress, and HIV-Related Care Among Older People Living with HIV During the COVID-19 Pandemic, Miami, Florida. AIDS Behav. 2020;24(8):2236-8.
Chen J, Cheng X, Wang R, Zeng X. Computed tomography imaging of an HIV-infected patient with coronavirus disease 2019. J Med Virol. 2020;92(10):1774-6.
Daneshfar M, Dadashzadeh N, Ahmadpour M, Ragati Haghi H, Rahmani V, Frouzesh M, et al. Lessons of mortality following COVID-19 epidemic in the United States especially in the geriatrics. J Nephropharmacol. 2021;10(1):e06.
Barzegar A GM, Rezaei N, Forouzesh M, Valizadeh, R. New hope for treatment of respiratory involvement following COVID-19 by bromhexine. J Nephropharmacol. 2021;2(10):e11.
Valizadeh R, Dadashzadeh N, Zakeri R, James Kellner S, Rahimi MM. Drug therapy in hospitalized patients with very severe symptoms following COVID-19. J Nephropharmacol. 2020;9(2):e21-e.
Härter G, Spinner CD, Roider J, Bickel M, Krznaric I, Grunwald S, et al. COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients. Infection. 2020;48(5):681-6.
Shalhoub S, AlZahrani A, Simhairi R, Mushtaq A. Successful recovery of MERS CoV pneumonia in a patient with acquired immunodeficiency syndrome: a case report. J Clin Virol. 2015;62:69-71.
Carrico AW, Horvath KJ, Grov C, Moskowitz JT, Pahwa S, Pallikkuth S, et al. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19. AIDS Behav. 2020;24(11):3020-3.
Guo W, Weng HL, Bai H, Liu J, Wei XN, Zhou K, et al. [Quick community survey on the impact of COVID-19 outbreak for the healthcare of people living with HIV]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(5):662-6.
Drain PK, Garrett N. SARS-CoV-2 pandemic expanding in sub- Saharan Africa: Considerations for COVID-19 in people living with HIV. EClinicalMedicine. 2020;22:100342.
Joska JA, Andersen L, Rabie S, Marais A, Ndwandwa E-S, Wilson P, et al. COVID-19: Increased Risk to the Mental Health and Safety of Women Living with HIV in South Africa. AIDS Behav. 2020;24(10):2751-3.
Jiang H, Zhou Y, Tang W. Maintaining HIV care during the COVID-19 pandemic. Lancet HIV. 2020;7(5):e308-e9. PubMed
Joob B, Wiwanitkit V. SARS-CoV-2 and HIV. J Med Virol. 2020;92(9):1415.
Ghosn J, Taiwo B, Seedat S, Autran B, Katlama C. HIV. Lancet. 2018;392(10148):685-697.
BNONews. Tracking coronavirus: MAP, data and timeline. Available at: https://bnonews.com/index.php/2020/02/the-latest-coronavirus-cases/. (Accessed 5 March 2020)
Cohen C, Moyes J, Tempia S, Groom M, Walaza S, Pretorius M, et al. Severe influenza-associated respiratory infection in high HIV prevalence setting, South Africa, 2009-2011. Emerg Infect Dis. 2013;19(11):1766-74.
Arabi YM, Arifi AA, Balkhy HH, Najm H, Aldawood AS, Ghabashi A, et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med. 2014;160(6):389-97.
Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361(9371):1767-72.
Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al- Hajjar S, Al-Barrak A, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013;13(9):752-61.
Xu Z, Zhang C, Wang FS. COVID-19 in people with HIV. Lancet HIV. 2020;7(8):e524-e6.
Cooper TJ, Woodward BL, Alom S, Harky A. Coronavirus disease 2019 (COVID-19) outcomes in HIV/AIDS patients: a systematic review. HIV Med. 2020;21(9):567-77.
Mak WW, Mo PK, Cheung RY, Woo J, Cheung FM, Lee D. Comparative stigma of HIV/AIDS, SARS, and tuberculosis in Hong Kong. Soc Sci Med. 2006;63(7):1912-22.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62.
Rajaei S, Dabbagh A. The immunologic basis of COVID-19: a clinical approach. J Cell Mol Anesth. 2020;5(1):37-42.
Mahmoodpoor A. SARS, MERS and COVID-19, the story continues. J Cell Mol Anesth. 2020;5(2):57-8.
Kalteh E, Sofizadeh A, Fararooei M, Ghelichi Ghojogh M, Alijalili S. Measures of Mortality in Coronavirus (COVID-19) Compared With SARS and MERS. J Cell Mol Anesth. 2020;5(2):97-101.
Darabi P, Bagherpour Kalo M, Mohamed Ali K, Safari S, Yousefifard M, Hosseini M. COVID-19:Features, Clinical Course and Concerns. J Cell Mol Anesth. 2020;5(2):102-13.
- Abstract Viewed: 299 times
- PDF Downloaded: 217 times